Invesco Ltd. Biotechnology

Invesco Ltd.

$499 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
BLUE Bluebird Bio, Inc.	$598M	$62,000 0.0% of portfolio	119,961	Q3 2024 Added 36.49%
NAUT Nautilus Biotechnology, Inc.	$213M	$58,000 0.0% of portfolio	20,620	Q3 2024 Reduced 2.94%
PROK Prokidney Corp Ord Shs Cl A(Cy	$102M	$58,000 0.0% of portfolio	30,480	Q3 2024 Added 9.39%
LCTX Lineage Cell Therapeutics, Inc.	$109M	$55,000 0.0% of portfolio	60,513	Q3 2024 Added 6.6%
AMRN Amarin Corp Plcuk	$234M	$53,000 0.0% of portfolio	85,544	Q3 2024 Added 44.2%
PDSB Pds Biotechnology Corp	$46.1M	$52,000 0.0% of portfolio	13,815	Q3 2024 Added 4.87%
MCRB Seres Therapeutics, Inc.	$104M	$52,000 0.0% of portfolio	55,218	Q3 2024 Added 40.65%
MGTX Meira G Tx Holdings PLC	$283M	$52,000 0.0% of portfolio	12,701	Q3 2024 Added 4.4%
FGEN Fibrogen Inc	$45M	$48,000 0.0% of portfolio	120,917	Q3 2024 Added 251.16%
KPTI Karyopharm Therapeutics Inc.	$49.5M	$48,000 0.0% of portfolio	58,152	Q3 2024 Added 43.55%
VERU Veru Inc.	$44.9M	$48,000 0.0% of portfolio	62,607	Q3 2024 Reduced 0.18%
CRDF Cardiff Oncology, Inc.	$174M	$47,000 0.0% of portfolio	17,805	Q3 2024 Reduced 2.06%
PBYI Puma Biotechnology, Inc.	$136M	$47,000 0.0% of portfolio	18,742	Q3 2024 Reduced 84.23%
ABOS Acumen Pharmaceuticals, Inc.	$64.4M	$45,000 0.0% of portfolio	18,189	Q3 2024 Reduced 4.2%
CTMX Cytom X Therapeutics, Inc.	$59.4M	$44,000 0.0% of portfolio	37,464	Q3 2024 Added 62.22%
RGLS Regulus Therapeutics Inc.	$14.6M	$44,000 0.0% of portfolio	28,253	Q3 2024 Reduced 2.78%
VXRT Vaxart, Inc.	$86M	$43,000 0.0% of portfolio	50,995	Q3 2024 Added 5.86%
PGEN Precigen, Inc.	$281M	$39,000 0.0% of portfolio	41,267	Q3 2024 Reduced 0.65%
CGEN Compugen LTD	$202M	$38,000 0.0% of portfolio	21,051	Q3 2024 Added 16.36%
OVID Ovid Therapeutics Inc.	$46.5M	$34,000 0.0% of portfolio	29,337	Q3 2024 Added 1.69%
ADAP Adaptimmune Therapeutics PLC	$98M	$33,000 0.0% of portfolio	34,809	Q3 2024 Added 0.19%
CVAC Cure Vac N.V.	$710M	$33,000 0.0% of portfolio	11,526	Q3 2024 Reduced 10.81%
GBIO Generation Bio Co.	$46M	$30,000 0.0% of portfolio	12,413	Q3 2024 Reduced 7.03%
QSI Quantum Si Inc	$236M	$29,000 0.0% of portfolio	33,365	Q3 2024 Reduced 5.18%
ABCL Ab Cellera Biologics Inc.	$904M	$28,000 0.0% of portfolio	10,950	Q3 2024 Reduced 20.32%
HOWL Werewolf Therapeutics, Inc.	$39.9M	$28,000 0.0% of portfolio	13,636	Q3 2024 Reduced 2.79%
RAPT Rapt Therapeutics, Inc.	$33.8M	$23,000 0.0% of portfolio	11,641	Q3 2024 Reduced 4.03%
ATNM Actinium Pharmaceuticals, Inc.	$30.5M	$22,000 0.0% of portfolio	12,166	Q3 2024 Added 1.38%
TNYA Tenaya Therapeutics, Inc.	$43M	$21,000 0.0% of portfolio	11,172	Q3 2024 Reduced 5.71%
ELEV Elevation Oncology, Inc.	$16.1M	$14,000 0.0% of portfolio	24,346	Q3 2024 Reduced 0.88%
LYRA Lyra Therapeutics, Inc.	$6.05M	$5,000 0.0% of portfolio	22,654	Q3 2024 Reduced 0.74%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	125,611	Q3 2024 Reduced 70.13%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.